 | • レポートコード：MRC23Q37849 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥406,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥812,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の医療用ソフトカプセル市場について調査・分析し、世界の医療用ソフトカプセル市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（ゼラチンタイプ、ノンアニマルタイプ）、用途別セグメント分析（病院、クリニック、医療機関、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、GSK、Aenova、Catalent、Boehringer Ingelheim、Nature’s Bounty、Patheon (Thermo Fisher Scientific)、Procaps、AstraZeneca、Aland、Vertex、Novartis、EuroCaps、Strides Pharma Science、Captek、Soft Gel Technologies、NextPharma (from Lonza)、Roche、Amway、Sirio Pharma Co., Ltd、Weihai Baihe Biology Technological Co., Ltd、Douglas、Shineway Pharma、Tsinghua Unigroup、Donghai Pharm、Yi Chao、Yuwang Groupなどが含まれています。世界の医療用ソフトカプセル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、医療用ソフトカプセル市場規模を推定する際に考慮しました。本レポートは、医療用ソフトカプセルの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、医療用ソフトカプセルに関するビジネス上の意思決定に役立てることを目的としています。 ・医療用ソフトカプセル市場の概要 - 製品の定義 - 医療用ソフトカプセルのタイプ別セグメント - 世界の医療用ソフトカプセル市場規模：タイプ別分析（ゼラチンタイプ、ノンアニマルタイプ） - 医療用ソフトカプセルの用途別セグメント - 世界の医療用ソフトカプセル市場規模：用途別分析（病院、クリニック、医療機関、その他） - 世界の医療用ソフトカプセル市場規模予測（2018年-2029年） - 医療用ソフトカプセルの平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 医療用ソフトカプセル市場の競争状況およびトレンド ・医療用ソフトカプセルの地域別市場規模 - 北米の医療用ソフトカプセル市場規模（2018年-2029年） - アメリカの医療用ソフトカプセル市場規模（2018年-2029年） - ヨーロッパの医療用ソフトカプセル市場規模（2018年-2029年） - アジア太平洋の医療用ソフトカプセル市場規模（2018年-2029年） - 中国の医療用ソフトカプセル市場規模（2018年-2029年） - 日本の医療用ソフトカプセル市場規模（2018年-2029年） - 韓国の医療用ソフトカプセル市場規模（2018年-2029年） - インドの医療用ソフトカプセル市場規模（2018年-2029年） - オーストラリアの医療用ソフトカプセル市場規模（2018年-2029年） - 中南米の医療用ソフトカプセル市場規模（2018年-2029年） - 中東・アフリカの医療用ソフトカプセル市場規模（2018年-2029年） ・タイプ別セグメント：ゼラチンタイプ、ノンアニマルタイプ - 世界の医療用ソフトカプセルのタイプ別販売量（2018年-2023年） - 世界の医療用ソフトカプセルのタイプ別売上（2018年-2023年） - 世界の医療用ソフトカプセルのタイプ別価格 ・用途別セグメント：病院、クリニック、医療機関、その他 - 世界の医療用ソフトカプセルの用途別販売量（2018年-2023年） - 世界の医療用ソフトカプセルの用途別売上（2018年-2023年） - 世界の医療用ソフトカプセルの用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 GSK、Aenova、Catalent、Boehringer Ingelheim、Nature’s Bounty、Patheon (Thermo Fisher Scientific)、Procaps、AstraZeneca、Aland、Vertex、Novartis、EuroCaps、Strides Pharma Science、Captek、Soft Gel Technologies、NextPharma (from Lonza)、Roche、Amway、Sirio Pharma Co., Ltd、Weihai Baihe Biology Technological Co., Ltd、Douglas、Shineway Pharma、Tsinghua Unigroup、Donghai Pharm、Yi Chao、Yuwang Group ・産業チェーンと販売チャネルの分析 - 医療用ソフトカプセル産業チェーン分析 - 医療用ソフトカプセルの主要原材料 - 医療用ソフトカプセルの販売チャネル - 医療用ソフトカプセルのディストリビューター - 医療用ソフトカプセルの主要顧客 ・医療用ソフトカプセル市場ダイナミクス - 医療用ソフトカプセルの業界動向 - 医療用ソフトカプセル市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Medical Soft Capsules market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Medical Soft Capsules is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Medical Soft Capsules is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Medical Soft Capsules include GSK, Aenova, Catalent, Boehringer Ingelheim, Nature’s Bounty, Patheon (Thermo Fisher Scientific), Procaps, AstraZeneca and Aland, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medical Soft Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Soft Capsules.
The Medical Soft Capsules market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Medical Soft Capsules market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Soft Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
GSK
Aenova
Catalent
Boehringer Ingelheim
Nature’s Bounty
Patheon (Thermo Fisher Scientific)
Procaps
AstraZeneca
Aland
Vertex
Novartis
EuroCaps
Strides Pharma Science
Captek
Soft Gel Technologies
NextPharma (from Lonza)
Roche
Amway
Sirio Pharma Co., Ltd
Weihai Baihe Biology Technological Co., Ltd
Douglas
Shineway Pharma
Tsinghua Unigroup
Donghai Pharm
Yi Chao
Yuwang Group
Segment by Type
Gelatin Type
Non-Animal Type
Segment by Application
Hospital
Clinic
Medical Institutions
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medical Soft Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medical Soft Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Medical Soft Capsules Market Overview
1.1 Product Overview and Scope of Medical Soft Capsules
1.2 Medical Soft Capsules Segment by Type
1.2.1 Global Medical Soft Capsules Market Value Comparison by Type (2023-2029)
1.2.2 Gelatin Type
1.2.3 Non-Animal Type
1.3 Medical Soft Capsules Segment by Application
1.3.1 Global Medical Soft Capsules Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Institutions
1.3.5 Others
1.4 Global Medical Soft Capsules Market Size Estimates and Forecasts
1.4.1 Global Medical Soft Capsules Revenue 2018-2029
1.4.2 Global Medical Soft Capsules Sales 2018-2029
1.4.3 Global Medical Soft Capsules Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Medical Soft Capsules Market Competition by Manufacturers
2.1 Global Medical Soft Capsules Sales Market Share by Manufacturers (2018-2023)
2.2 Global Medical Soft Capsules Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Medical Soft Capsules Average Price by Manufacturers (2018-2023)
2.4 Global Medical Soft Capsules Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Medical Soft Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Soft Capsules, Product Type & Application
2.7 Medical Soft Capsules Market Competitive Situation and Trends
2.7.1 Medical Soft Capsules Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medical Soft Capsules Players Market Share by Revenue
2.7.3 Global Medical Soft Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medical Soft Capsules Retrospective Market Scenario by Region
3.1 Global Medical Soft Capsules Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Medical Soft Capsules Global Medical Soft Capsules Sales by Region: 2018-2029
3.2.1 Global Medical Soft Capsules Sales by Region: 2018-2023
3.2.2 Global Medical Soft Capsules Sales by Region: 2024-2029
3.3 Global Medical Soft Capsules Global Medical Soft Capsules Revenue by Region: 2018-2029
3.3.1 Global Medical Soft Capsules Revenue by Region: 2018-2023
3.3.2 Global Medical Soft Capsules Revenue by Region: 2024-2029
3.4 North America Medical Soft Capsules Market Facts & Figures by Country
3.4.1 North America Medical Soft Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Medical Soft Capsules Sales by Country (2018-2029)
3.4.3 North America Medical Soft Capsules Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Soft Capsules Market Facts & Figures by Country
3.5.1 Europe Medical Soft Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Medical Soft Capsules Sales by Country (2018-2029)
3.5.3 Europe Medical Soft Capsules Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Soft Capsules Market Facts & Figures by Country
3.6.1 Asia Pacific Medical Soft Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Medical Soft Capsules Sales by Country (2018-2029)
3.6.3 Asia Pacific Medical Soft Capsules Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Medical Soft Capsules Market Facts & Figures by Country
3.7.1 Latin America Medical Soft Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Medical Soft Capsules Sales by Country (2018-2029)
3.7.3 Latin America Medical Soft Capsules Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medical Soft Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Soft Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Medical Soft Capsules Sales by Country (2018-2029)
3.8.3 Middle East and Africa Medical Soft Capsules Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Soft Capsules Sales by Type (2018-2029)
4.1.1 Global Medical Soft Capsules Sales by Type (2018-2023)
4.1.2 Global Medical Soft Capsules Sales by Type (2024-2029)
4.1.3 Global Medical Soft Capsules Sales Market Share by Type (2018-2029)
4.2 Global Medical Soft Capsules Revenue by Type (2018-2029)
4.2.1 Global Medical Soft Capsules Revenue by Type (2018-2023)
4.2.2 Global Medical Soft Capsules Revenue by Type (2024-2029)
4.2.3 Global Medical Soft Capsules Revenue Market Share by Type (2018-2029)
4.3 Global Medical Soft Capsules Price by Type (2018-2029)
5 Segment by Application
5.1 Global Medical Soft Capsules Sales by Application (2018-2029)
5.1.1 Global Medical Soft Capsules Sales by Application (2018-2023)
5.1.2 Global Medical Soft Capsules Sales by Application (2024-2029)
5.1.3 Global Medical Soft Capsules Sales Market Share by Application (2018-2029)
5.2 Global Medical Soft Capsules Revenue by Application (2018-2029)
5.2.1 Global Medical Soft Capsules Revenue by Application (2018-2023)
5.2.2 Global Medical Soft Capsules Revenue by Application (2024-2029)
5.2.3 Global Medical Soft Capsules Revenue Market Share by Application (2018-2029)
5.3 Global Medical Soft Capsules Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GSK Medical Soft Capsules Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Aenova
6.2.1 Aenova Corporation Information
6.2.2 Aenova Description and Business Overview
6.2.3 Aenova Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Aenova Medical Soft Capsules Product Portfolio
6.2.5 Aenova Recent Developments/Updates
6.3 Catalent
6.3.1 Catalent Corporation Information
6.3.2 Catalent Description and Business Overview
6.3.3 Catalent Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Catalent Medical Soft Capsules Product Portfolio
6.3.5 Catalent Recent Developments/Updates
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Corporation Information
6.4.2 Boehringer Ingelheim Description and Business Overview
6.4.3 Boehringer Ingelheim Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Boehringer Ingelheim Medical Soft Capsules Product Portfolio
6.4.5 Boehringer Ingelheim Recent Developments/Updates
6.5 Nature’s Bounty
6.5.1 Nature’s Bounty Corporation Information
6.5.2 Nature’s Bounty Description and Business Overview
6.5.3 Nature’s Bounty Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Nature’s Bounty Medical Soft Capsules Product Portfolio
6.5.5 Nature’s Bounty Recent Developments/Updates
6.6 Patheon (Thermo Fisher Scientific)
6.6.1 Patheon (Thermo Fisher Scientific) Corporation Information
6.6.2 Patheon (Thermo Fisher Scientific) Description and Business Overview
6.6.3 Patheon (Thermo Fisher Scientific) Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Patheon (Thermo Fisher Scientific) Medical Soft Capsules Product Portfolio
6.6.5 Patheon (Thermo Fisher Scientific) Recent Developments/Updates
6.7 Procaps
6.6.1 Procaps Corporation Information
6.6.2 Procaps Description and Business Overview
6.6.3 Procaps Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Procaps Medical Soft Capsules Product Portfolio
6.7.5 Procaps Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.8.4 AstraZeneca Medical Soft Capsules Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Aland
6.9.1 Aland Corporation Information
6.9.2 Aland Description and Business Overview
6.9.3 Aland Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Aland Medical Soft Capsules Product Portfolio
6.9.5 Aland Recent Developments/Updates
6.10 Vertex
6.10.1 Vertex Corporation Information
6.10.2 Vertex Description and Business Overview
6.10.3 Vertex Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Vertex Medical Soft Capsules Product Portfolio
6.10.5 Vertex Recent Developments/Updates
6.11 Novartis
6.11.1 Novartis Corporation Information
6.11.2 Novartis Medical Soft Capsules Description and Business Overview
6.11.3 Novartis Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Novartis Medical Soft Capsules Product Portfolio
6.11.5 Novartis Recent Developments/Updates
6.12 EuroCaps
6.12.1 EuroCaps Corporation Information
6.12.2 EuroCaps Medical Soft Capsules Description and Business Overview
6.12.3 EuroCaps Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.12.4 EuroCaps Medical Soft Capsules Product Portfolio
6.12.5 EuroCaps Recent Developments/Updates
6.13 Strides Pharma Science
6.13.1 Strides Pharma Science Corporation Information
6.13.2 Strides Pharma Science Medical Soft Capsules Description and Business Overview
6.13.3 Strides Pharma Science Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Strides Pharma Science Medical Soft Capsules Product Portfolio
6.13.5 Strides Pharma Science Recent Developments/Updates
6.14 Captek
6.14.1 Captek Corporation Information
6.14.2 Captek Medical Soft Capsules Description and Business Overview
6.14.3 Captek Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Captek Medical Soft Capsules Product Portfolio
6.14.5 Captek Recent Developments/Updates
6.15 Soft Gel Technologies
6.15.1 Soft Gel Technologies Corporation Information
6.15.2 Soft Gel Technologies Medical Soft Capsules Description and Business Overview
6.15.3 Soft Gel Technologies Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Soft Gel Technologies Medical Soft Capsules Product Portfolio
6.15.5 Soft Gel Technologies Recent Developments/Updates
6.16 NextPharma (from Lonza)
6.16.1 NextPharma (from Lonza) Corporation Information
6.16.2 NextPharma (from Lonza) Medical Soft Capsules Description and Business Overview
6.16.3 NextPharma (from Lonza) Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.16.4 NextPharma (from Lonza) Medical Soft Capsules Product Portfolio
6.16.5 NextPharma (from Lonza) Recent Developments/Updates
6.17 Roche
6.17.1 Roche Corporation Information
6.17.2 Roche Medical Soft Capsules Description and Business Overview
6.17.3 Roche Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Roche Medical Soft Capsules Product Portfolio
6.17.5 Roche Recent Developments/Updates
6.18 Amway
6.18.1 Amway Corporation Information
6.18.2 Amway Medical Soft Capsules Description and Business Overview
6.18.3 Amway Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Amway Medical Soft Capsules Product Portfolio
6.18.5 Amway Recent Developments/Updates
6.19 Sirio Pharma Co., Ltd
6.19.1 Sirio Pharma Co., Ltd Corporation Information
6.19.2 Sirio Pharma Co., Ltd Medical Soft Capsules Description and Business Overview
6.19.3 Sirio Pharma Co., Ltd Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Sirio Pharma Co., Ltd Medical Soft Capsules Product Portfolio
6.19.5 Sirio Pharma Co., Ltd Recent Developments/Updates
6.20 Weihai Baihe Biology Technological Co., Ltd
6.20.1 Weihai Baihe Biology Technological Co., Ltd Corporation Information
6.20.2 Weihai Baihe Biology Technological Co., Ltd Medical Soft Capsules Description and Business Overview
6.20.3 Weihai Baihe Biology Technological Co., Ltd Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Weihai Baihe Biology Technological Co., Ltd Medical Soft Capsules Product Portfolio
6.20.5 Weihai Baihe Biology Technological Co., Ltd Recent Developments/Updates
6.21 Douglas
6.21.1 Douglas Corporation Information
6.21.2 Douglas Medical Soft Capsules Description and Business Overview
6.21.3 Douglas Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Douglas Medical Soft Capsules Product Portfolio
6.21.5 Douglas Recent Developments/Updates
6.22 Shineway Pharma
6.22.1 Shineway Pharma Corporation Information
6.22.2 Shineway Pharma Medical Soft Capsules Description and Business Overview
6.22.3 Shineway Pharma Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Shineway Pharma Medical Soft Capsules Product Portfolio
6.22.5 Shineway Pharma Recent Developments/Updates
6.23 Tsinghua Unigroup
6.23.1 Tsinghua Unigroup Corporation Information
6.23.2 Tsinghua Unigroup Medical Soft Capsules Description and Business Overview
6.23.3 Tsinghua Unigroup Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.23.4 Tsinghua Unigroup Medical Soft Capsules Product Portfolio
6.23.5 Tsinghua Unigroup Recent Developments/Updates
6.24 Donghai Pharm
6.24.1 Donghai Pharm Corporation Information
6.24.2 Donghai Pharm Medical Soft Capsules Description and Business Overview
6.24.3 Donghai Pharm Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.24.4 Donghai Pharm Medical Soft Capsules Product Portfolio
6.24.5 Donghai Pharm Recent Developments/Updates
6.25 Yi Chao
6.25.1 Yi Chao Corporation Information
6.25.2 Yi Chao Medical Soft Capsules Description and Business Overview
6.25.3 Yi Chao Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.25.4 Yi Chao Medical Soft Capsules Product Portfolio
6.25.5 Yi Chao Recent Developments/Updates
6.26 Yuwang Group
6.26.1 Yuwang Group Corporation Information
6.26.2 Yuwang Group Medical Soft Capsules Description and Business Overview
6.26.3 Yuwang Group Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.26.4 Yuwang Group Medical Soft Capsules Product Portfolio
6.26.5 Yuwang Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Soft Capsules Industry Chain Analysis
7.2 Medical Soft Capsules Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Soft Capsules Production Mode & Process
7.4 Medical Soft Capsules Sales and Marketing
7.4.1 Medical Soft Capsules Sales Channels
7.4.2 Medical Soft Capsules Distributors
7.5 Medical Soft Capsules Customers
8 Medical Soft Capsules Market Dynamics
8.1 Medical Soft Capsules Industry Trends
8.2 Medical Soft Capsules Market Drivers
8.3 Medical Soft Capsules Market Challenges
8.4 Medical Soft Capsules Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer